Mbata, M.K.; Hunziker, M.; Makhdoomi, A.; Lüthi-Corridori, G.; Boesing, M.; Giezendanner, S.; Muser, J.; Leuppi-Taegtmeyer, A.B.; Leuppi, J.D.
Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study. J. Clin. Med. 2023, 12, 5520.
https://doi.org/10.3390/jcm12175520
AMA Style
Mbata MK, Hunziker M, Makhdoomi A, Lüthi-Corridori G, Boesing M, Giezendanner S, Muser J, Leuppi-Taegtmeyer AB, Leuppi JD.
Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study. Journal of Clinical Medicine. 2023; 12(17):5520.
https://doi.org/10.3390/jcm12175520
Chicago/Turabian Style
Mbata, Munachimso Kizito, Mireille Hunziker, Anja Makhdoomi, Giorgia Lüthi-Corridori, Maria Boesing, Stéphanie Giezendanner, Jürgen Muser, Anne B. Leuppi-Taegtmeyer, and Jörg D. Leuppi.
2023. "Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study" Journal of Clinical Medicine 12, no. 17: 5520.
https://doi.org/10.3390/jcm12175520
APA Style
Mbata, M. K., Hunziker, M., Makhdoomi, A., Lüthi-Corridori, G., Boesing, M., Giezendanner, S., Muser, J., Leuppi-Taegtmeyer, A. B., & Leuppi, J. D.
(2023). Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study. Journal of Clinical Medicine, 12(17), 5520.
https://doi.org/10.3390/jcm12175520
